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Sodium butyrate is very often used to alter gene 
expression  in  cultured cells. In  this  study,  we  examined 
the effects of this compound on various  cellular  events 
in WI-38 human  embryonic  lung  fibroblasts in culture. 
During a 16-20-h  treatment  at sodium butyrate con- 
centrations of between 5 and  20 mM, no  adverse  effects 
on cell  morphology were observed.  However,  cell di- 
vision and DNA synthesis  were  reversibly  inhibited, 
the  latter by 85, 80, and 70% at sodium butyrate con- 
centrations of 5,10, and  20 mM, respectively.  Although 
overall  protein  synthetic  activity  was  not  significantly 
affected, RNA synthesis  decreased  to 76% of the con- 
trol  values at  a sodium butyrate  concentration of 5 mM. 
Butyrate  treatment  also caused hypermethylation of 
DNA cytosines as determined by differential digestion 
by MspIIHpaII restriction endonucleases and by high 
performance liquid chromatography analysis of the 
DNA. The 5-methylcytosine content of the DNA in 
untreated WI-38 fibroblasts  was 2.94 f 0.46% of total 
cytosine  residues,  while in  cultures  treated  with 5, 10, 
and 20 mM sodium butyrate,  these  values  were 5.76 -C 
0.28, 5.91 f 0.37, and 6.8 -C 0.44%,  respectively. An 
interesting  feature is that  this  hypermethylation oc- 
curred  in DNA which  was  synthesized  in  the  presence 
of sodium butyrate  (newly  synthesized) as well as in 
DNA which had been synthesized before butyrate 
administration  (pre-existing DNA). The  hypermethyl- 
ated  state  was  conserved only in  the  former  situation, 
since  the methylcytosines were  rapidly lost  in the  sub- 
sequent  generation  in  the  latter case. It would there- 
fore  appear  that methylcytosines are maintained after 
cell replication only if they are generated  on newly 
synthesized DNA. 
The four-carbon fatty acid, sodium butyrate, has a wide 
variety of morphological and biochemical  effects on cells in 
culture (1, 2). Some of the early studies on the effects of 
sodium butyrate showed that  it  inhibited cell growth,  probably 
by arresting cells in the  G1  phase of the cell cycle (3,4).  This 
G1 arrest  appears  to be a specific inhibition at  the  G1  to S 
phase  transition  point,  but may  also be indirect since butyrate 
affects  a large number of cellular  processes and enzyme activ- 
ities.  Effects  such  as  inhibition of DNA replication (5-7) and 
stimulation of DNA repair  synthesis  in  ultraviolet-irradiated 
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fibroblasts have  also  been  shown to occur (8, 9). 
The  best  studied effect of sodium butyrate is perhaps  the 
reversible  hyperacetylation of histones  H3  and  H4  and,  to a 
lesser extent, that of the histones H2A and H2B (10-13), 
resulting  in increased sensitivity  to micrococcal nuclease  (14) 
and increased transcriptional  activity (15, 16). Hyperacetyla- 
tion  is  due  to  inhibition of the deacetylase and  not  to  stimu- 
lation of the acetylase. Hyperphosphorylation of histone H2A 
(4, 5), as well as  the high mobility group proteins HMG14 
and -17 (17), has also been observed. Other effects include 
inhibition of protein  methylation ( 5 ) ,  diminished RNA  polym- 
erase  activity due to a decreased concentration of RNA  polym- 
erase molecules (18),  and  stimulation of ADP-ribose  polym- 
erase activity. Thus, sodium butyrate affects the  activity of 
several  nuclear  enzymes and  it  is  not  yet clear whether  these 
multiple  effects are  due  to a single molecular event or whether 
butyrate  acts  at various levels. 
Understanding  the mode of action of sodium butyrate is 
complicated even further by the fact that individual genes 
appear  to be affected  differently in different cell types. The 
studies of Reeves and Cserjesi (19)  and Leibovitch et al. (20) 
have shown that sodium butyrate induces new gene expression 
in Friend erythroleukemia cells. Analysis of hybridization 
kinetics showed that as many as 3000 new genes may be 
transcribed. Examples of specific genes include globin gene 
expression  in murine erythroleukemia cells (21) and induction 
of oncodevelopmental proteins  such  as  alkaline  phosphatase, 
chorionic  gonadotropin, and P-glycoprotein in a cervical car- 
cinoma cell line  (22).  A very interesting feature of gene 
induction by butyrate  is  its ynergistic  behavior when used  in 
combination with other inducers; for example, the induction 
of &adrenergic  receptors in  HeLa cells (23) and  fetal hemo- 
globin in  adult  chickens (24) after 5-azacytidine administra- 
tion. 
The mode of action of sodium butyrate  in gene activation 
or repression is presently  not fully understood,  but  it  is known 
that  induction of globin gene expression  with  inducers such 
as  dimethyl sulfoxide and  ethionine  results in hypermethyla- 
tion of the globin genes in a murine  erythroleukemia cell line 
(25-27). Although DNA hypomethylation  is generally  associ- 
ated with gene activation (28-30), genomic rearrangement 
(31) could play a major role in gene induction. 
Most of the above mentioned  studies were performed on 
transformed cells and  it  is possible that some of the effects 
observed are peculiar to  “immortal cells.” In  this  study, we 
have  examined  the ffects of sodium butyrate  on  the  “mortal” 
fibroblast cell line, WI-38, and have found  it  to cause hyper- 
methylation of cytosine  residues  in the  total DNA. Further- 
more,  only those  sites which are  hypermethylated  in  the n wly 
synthesized  DNA are  maintained  after  the removal of butyr- 
ate, while hypermethylation occurring on “old” or pre-existing 
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DNA strands does not persist once the stimulus has been 
removed. 
MATERIALS AND METHODS 
Cell Culture-WI-38 fibroblasts were obtained from ATCC (ATCC 
CL-75). Cells were maintained  in Eagle's Basal Medium containing 
10% fetal calf serum and 100 Fg/ml penicillin and 100 units/ml 
streptomycin. At confluence, the cells were split a t  a ratio of 1:2. 
Cells were trypsinized with 0.05% trypsin in Ca2+- and M$+-free 
phosphate-buffered  saline  containing  10 mM EDTA and counted in 
a  Coulter Counter (Coulter  Electronics). 
DNA, RNA, and  Protein Synthesis-Cells were seeded at  5 X lo4/ 
7-cm2 dish. Twenty h later, [3H]thymidine,  [3H]uridine, or [3H]leucine 
(all from Amersham, at 40 Ci/mmol, 43 Ci/mmol, and 50 Ci/mmol, 
respectively) was added a t  1 pCi/ml in the presence of the specified 
concentrations of sodium butyrate. After the indicated  time period, 
the cells were trypsinized and  an aliquot was counted.  Trichloroacetic 
acid was added to  the balance of the cells to a  final  concentration of 
10%. After 1 h  on ice, the samples were filtered onto  Whatman  GF/ 
C filters. When the cells were labeled with [3H]uridine, a 10 p~ 
concentration each of deoxycytidine and thymidine was added in 
order to reduce incorporation of the label into DNA via the salvage 
pathways. 
DNA-Agarose Gels-Cells were grown in 150-cm2 flasks and  treated 
with the indicated concentrations of sodium butyrate,  and  the DNA 
was isolated as previously described (32). Briefly, cells were lysed in 
1% sodium dodecyl sulfate, 1 mM EDTA  and incubated with 100 pg/ 
ml Proteinase K for 4 h at  50 "C. Samples were extracted with an 
equal volume of phenol saturated with TE  (10 mM Tris-HC1, pH 7.5, 
1 mM EDTA), until no protein interphase was visible. After two 
extractions with chloroform: isoamyl alcohol (24:1), the DNA was 
precipitated by the addition of 0.1 volume of 3 M sodium acetate  and 
2.5 volumes of ethanol at  -20 "C for 1 h. The DNA pellet was washed 
three times in 70% ethanol and dissolved in TE buffer. DNA was 
digested for 2 h with 5 units of HpaII or MspI per pg of DNA as 
described by the manufacturers  (New  England Biolabs or Boehringer 
Mannheim). Samples were electrophoresed  on 1% horizontal agarose 
gels and  stained with  ethidium bromide. The negatives were scanned 
in a Cliniscan densitometer  (Helena,  Beaumont, TX). 
High Performance Liquid Chromatography Analysis-For 5-meth- 
ylcytosine analysis, the cells were grown in 60-cm2  dishes until  treated 
with the various concentrations of sodium butyrate. Cells were either 
prelabeled for 3 days with [6-3H]uridine, rinsed, and treated with 
butyrate,  or  treated simultaneously  with  [6-3H]uridine and butyrate. 
In both  cases, the  butyrate  treatment was for 16-20 h. After treat- 
ment, the medium was removed and  the cell layer was rinsed with 
phosphate-buffered  saline and lysed in 0.5% SDS, 0.3 N NaOH before 
being incubated at  37 "C for 16 h ( 3 3 ) .  The incubate was neutralized 
by the addition of Tris-HC1, pH 7.5, to a  final  concentration of 50 
mM and HC1 to 0.3 N. Proteins were digested for a further 24 h by 
the addition of Proteinase K to a final concentration of 100 pg/ml. 
The DNA was precipitated by the addition of an equal volume of 10% 
trichloroacetic acid and left at  4 "C for 1 h. The DNA was pelleted, 
rinsed in 70% ethanol,  and hydrolyzed in 88% formic acid at  180 "C 
for 25 min in sealed capillary tubes. The formic acid was evaporated 
and  the hydrolysate was resuspended in 0.1 N HC1. Analysis for 5- 
methylcytosine content was performed by high performance liquid 
chromatography  on  a  Beckman  Ultracil Cx column. The percentage 
of cytosines (C)  that were converted to 5-methylcytosine  (5-mC) was 
calculated as follows: 
% 5mC = 
dpm in 5-mC 
dpm in 5-mC + C x 100 
In  the dual-labeling  experiments, cells were treated with [14C]uridine 
for 3 days prior to butyrate treatment, followed by [6-3H]uridine 
during or after  treatment. 
RESULTS 
Cell Growth-Sodium butyrate  addition  inhibited cell divi- 
sion in WI-38 fibroblasts, even a t  concentrations of 5 mM 
(Fig. 1). Determination of cell viability by trypan blue  exclu- 
sion,  on  the  other  hand, showed that  this  property was not 
affected by either sodium butyrate  or sodium  chloride. Butyr- 
ate  inhibition of cell growth a t  concentrations  as high as 50 
mM (data  not  shown) was such  that  the cells were still viable 
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FIG. 1. Cell growth in the presence of increasing concentra- 
tions of sodium butyrate. Cells were seeded at  lo5 cells/30-mm 
diameter dish. Sixteen  h  later, the medium was replaced with fresh 
medium containing sodium butyrate, at  either 5 mM (A-A) or 10 
mM (U). The effect of sodium ions was monitored by treating 
the cells with 10 mM NaCl (*-*). Cells were trypsinized and 
counted as described under  "Materials and Methods." W, con- 
trol cells in the absence of the two salts. Bars indicate standard 
deviations. 
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FIG. 2. Measurement of DNA (U), RNA (M), and 
protein (A-A) synthesis in WI-38 fibroblasts during 16-20 
h treatment periods at various concentrations of sodium bu- 
tyrate. DNA synthesis was measured by the incorporation of [3H] 
thymidine into trichloroacetic  acid-precipitable  material, while RNA 
and protein  synthesis were monitored by incorporation of [3H]uridine 
and [3H]leucine into trichloroacetic acid-precipitable material, re- 
spectively (see "Materials and Methods"). Bars indicate standard 
deviations. 
and  able  to resume  growth after  butyrate removal. 
DNA,  RNA, and  Protein Synthesis-Sodium butyrate  has 
previously  been  shown to  inhibit replicative  DNA synthesis 
(5-7). Although DNA synthesis  in WI-38 cells was inhibited 
by approximately 85% at 5 mM butyrate, RNA synthesis was 
inhibited by only 20% and  protein  synthesis was unaffected 
(Fig. 2). Maximum inhibition of DNA synthesis (85%) oc- 
curred a t  5 mM butyrate, while the  inhibition of RNA synthe- 
sis did not display this  kind of dose response. Protein  synthe- 
sis was minimally inhibited at  5 mM butyrate;  it is therefore 
improbable that inhibition of DNA synthesis was due to 
inhibition of protein  synthesis. 
DNA Methylation-Using the digestion patterns  obtained 
with the HpaIIIMspI restriction endonuclease pair, we ex- 
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FIG. 3. Methylation analysis of DNA from control and bu- 
tyrate-treated cells by digestion with  either MspI or HpuII. 
DNA was digested at  5 units of enzymelpg of DNA,  electrophoresed 
on a 1% agarose gel, and stained with ethidium  bromide. The  nega- 
tives were scanned with a Cliniscan densitometer. -, untreated; 
-” , 5 mM; . . . . , 10 mM; o”--o, 20 mM sodium butyrate. 
amined  the  extent of cytosine  hypermethylation,  if  any,  after 
butyrate  treatment of WI-38 cells. Fig. 3 shows a densitome- 
tric  scan of DNA samples isolated from cells either  untreated 
or given 5, 10, or 20 mM sodium butyrate and subjected to 
electrophoresis on 1% agarose gels after digestion  with either 
HpaII or MspI. Butyrate treatment of cells caused a shift 
toward the high molecular weight region after restriction 
endonuclease  digestion and  this  shift occurred  in both  HpaII- 
and  MspI-digested  samples, showing that  hypermethylation 
occurred at  both  cytosines  in  the r cognition  sequence CCGG. 
This shows that CpC methylation was  induced together with 
that of CpG sequences. The molecular weight shift was greater 
in the  MspI-digested samples, indicating  that significant  CpC 
methylation probably  occurred  even at  5 mM butyrate.  Higher 
levels of methylation were observed a t  5 mM than  at  either 
10 or 20 mM butyrate. 
In  order  to  determine  the  extent of DNA  hypermethylation, 
the cells were treated with [6-3H]uridine as previously de- 
scribed (33)  and  the conversion of cytosine to  5-methylcyto- 
sine was determined by high performance liquid  chromatog- 
raphy  analysis of the bases after formic  acid hydrolysis. There 
was a large increase in the  5-methylcytosine  content of DNA 
from 2,94% in control cells to 5.76% in 5 mM butyrate-treated 
cells, followed by a  more  gradual  increase to 6.8% at 20 mM 
butyrate (Fig. 4). At butyrate concentrations of 50-75 mM 
(where  NaCl showed no adverse effects),  the 5-methylcytosine 
levels declined  back to  control values (data  not  shown).  Since 
the DNA was labeled before butyrate  administration,  analysis 
of “H-labeled 5-methylcytosine in this case would indicate 
methylation of pre-existing DNA strands.  Similar increases 
in 5-methylcytosine levels were obtained in cells treated with 
butyrate  and [6-’H]uridine concurrently (Fig. 4). In  this case, 
however, only the DNA strands  synthesized  during  the  butyr- 
ate  treatment period were labeled and  methylation of these 
newly synthesized DNA strands was assessed. It was thus 
evident that  both  pre-existing  and newly synthesized DNA 
strands were hypermethylated as a result of sodium butyrate 
treatment, with hypermethylation being greater  in  the case 
of pre-existing DNA strands.  In  fact,  pre-existing DNA strand 
methylation was increased to 5.76% even at  5 mM butyrate, 
while newly synthesized DNA strands showed no significant 
increase  in  5-methylcytosine  content at  this low concentra- 
tion of butyrate. 
Maintenance of the Hypermethylated State-In order to 
determine  whether  the increased methylation  status induced 
by sodium butyrate was stable  during  subsequent cell division, 
cells were analyzed for  the 5-methylcytosine content of their 
DNA 24 h after  butyrate  treatment, when  a single round of 
replication had occurred in  the  asynchronous cultures. DNA 
was labeled with  [6-3H]uridine  for  3  days, followed by sodium 
butyrate  treatment for 16 h in  order  to  examine  methylation 
of pre-existing DNA strands,  alternatively, labeling was done 
overnight in  the presence of butyrate for analysis of newly 
synthesized DNA strands.  Since  the lowest concentration of 
sodium butyrate at which hypermethylation of both pre- 
existing  and newly synthesized DNA strands occurred was 10 
mM, the experiments were done at this concentration of 
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FIG. 4. DNA hypermethylation analysis by high perform- 
ance  liquid chromatography. Cells were either  prelaheled  with (6- 
3H]uridine followed by butyrate treatment (pre-existing DNA 
strands) or labeled concurrently with butyrate treatment (newly 
synthesized DNA strands). After 16-20 h in the presence of butyrate, 
DNA was isolated  and the 5-methylcytosine content was determined 
as described  under “Materials  and  Methods” ( n  = 12). Burs indicate 
standard deviations. 
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FIG. 5. Stability of the hypermethylation status  in butyrate- 
treated cells. Cells were either  prelabeled (pre-existing DNA 
strands) or labeled concurrently (newly synthesized DNA strands) 
with [6-’HH]uridine during butyrate treatment as described in the 
legend to Fig. 4. Half the flasks were then  removed  and  changed to 
fresh medium for 24 h, while the other set was analyzed for 5- 
methylcytosine content immediately.  Number of determinations per 
experiment = 8. Burs indicate standard deviations. 
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FIG. 6. Dual label analysis of the  stability of DNA hyper- 
methylation. WI-38 cells were prelabeled with [I4C]uridine for 3 
days. After extensive washing of the cell layer, medium containing 
[6-:’H]uridine plus 10 mM sodium butyrate was added. The  5-meth- 
ylcytosine content of the DNA samples was determined in the follow- 
ing cases. a, 16  h after  the  addition of [6-3H]uridine to “C-prelabeled 
cells without  butyrate  addition; b, as in a above,  except that 10 mM 
sodium butyrate was added together with the [6-3H]uridine for the 
16-h pulse; c, as in b above, except  that  the cells were allowed to grow 
with  no additions for an  additional 24 h after  the  16-h pulse in  the 
presence of 10 mM butyrate. Bars indicate  standard deviations. 
butyrate. To  our  surprise, only those  additional 5-methylcy- 
tosine residues which were added  to  the newly synthesized 
DNA were conserved (Fig. 5) while those occurring on the 
pre-existing DNA strands were not conserved. Because the 
above determinations had been made in separate cultures, 
dual label experiments were also performed  in order  to  con- 
firm  the above findings with respect to  the  maintenance of 
the  methylation  status of pre-existing  and newly synthesized 
DNA strands  in  the  same  cultures. Cells were prelabeled  with 
[‘*C]uridine  for  3  days, followed by [3H]uridine  plus sodium 
butyrate for 16 h. This design  ruled out  variations from  dish 
to dish or between experiments.  The  results (Fig. 6) were in 
exact agreement with those shown in Fig. 5: 5-[14C]methyl- 
cytosines  present  on  pre-existing DNA strands were not  con- 
served,  while the  5-[3H]methylcytosines  on  the n wly synthe- 
sized DNA  strands were retained  in  daughter cells. This  dual- 
labeling experiment  incidently  also confirmed the  finding  that 
the  extent of hypermethylation was much  greater in the  pre- 
existing DNA strands than in the newly synthesized DNA 
strands. 
DISCUSSION 
Our results  are  in  general  agreement with those of other 
workers on  the effects of sodium butyrate  on cell growth and 
DNA synthesis  in  chicken  fibroblasts  and  HeLa cells (5-7). 
WI-38  human embryonic  lung fibroblasts showed a  reversible 
growth arrest at butyrate concentrations below 20 mM, al- 
though the cells could tolerate higher concentrations. By 
contrast, simian virus 40 (SV40)-transformed WI-38 fibro- 
blasts were much more sensitive  to sodium butyrate, even at  
concentrations  as low as 5 and 10 mM (35). 
Analysis of macromolecular synthesis showed that  although 
DNA  synthesis was drastically  affected by butyrate, RNA and 
protein synthesis were much less affected. In fact, protein 
synthesis was  only  marginally  affected,  with  significant inhi- 
bition occurring only at  concentrations of 20 mM butyrate 
and higher. Therefore, a  general impediment  in  the  synthesis 
of proteins did not cause the  inhibition of DNA synthesis  and 
cell growth.  Several studies have  shown that sodium butyrate 
does not  inhibit major  mRNA or protein  synthesis,  but  that 
new gene products may be induced (for review see Ref. 2). 
Whether a gene is to be activated or inhibited by sodium 
butyrate  is probably dependent  on a specific precondition of 
the  chromatin  and/or  the cell type being treated. It is there- 
fore conceivable that only those genes  having the  potential  to 
be activated will be induced by sodium butyrate (or any  other 
inducer).  It is also possible that a specific pre-existing  chro- 
matin  structure  and/or chromosomal factors guide enzymes 
such  as DNA methyltransferases  to  certain  restricted groups 
or sites  on  the DNA, resulting in the observed effects. That 
is, inducers themselves are nonspecific, but gene-specific ac- 
tivation  is  due  to  the  particular  conformation f the genes  in 
chromatin. 
One of the significant  findings of our  study was that  butyr- 
ate caused hypermethylation of cytosine  residues in  the DNA 
of butyrate-treated cells. Several studies have  indicated that 
methylation per se may not be the  only  controlling mechanism 
of gene activity.  We  have previously shown that loss of type 
I procollagen gene expression in SV40-transformed cells is 
associated  with hypermethylation of these genes (32),  but  that 
demethylation of these sites with the cytosine analogue 5- 
azacytidine  (34)  does not cause  expression of the type I 
procollagen genes  (36). It is also possible that a subset of 5- 
methylcytosine  residues is important in the regulation of gene 
expression,  since  McKeon et al. (37) have  shown that  meth- 
ylation of certain cytosine residues has  no correlation with 
activity of the  type I procollagen genes. In  this case,  our study 
does not prove that  butyrate “switches off‘ 20% of the genes 
in  WI-38 cells as  it is also possible that  the overall transcrip- 
tional  activity  is only 80% efficient in  the presence of butyrate. 
Previous studies have shown that DNA methylation is 
tightly coupled to DNA  replication (38, 39) and  the  fact  that 
most of the 5-methylcytosines occur in  the dinucleotide CpG 
provides  a mechanism for the  heritable  transmission of meth- 
ylation  patterns  (30). Our results show that  butyrate  treat- 
ment was not only  associated  with the  methylation of cyto- 
sines at  CpG sequences, but also at  CpC sites (Fig. 3).  This 
restriction endonuclease assay showed that higher levels of 
CCGG methylation were obtained a t  5 mM than  at 10 or 20 
mM butyrate. However, high performance liquid chromatog- 
raphy analysis (Fig. 4) showed that the 5-methylcytosine 
content began to  plateau  at 5 mM, such  that  no significant 
further  change occurred at  either 10 or 20 mM butyrate.  The 
only possible explanation for this discrepancy is that more 
erratic methylation (Le. at non-CpG sites) occurred at the 
higher butyrate concentrations and therefore could not be 
detected by digestion with MspI. A second and unexpected 
result was that only  some of these  hypermethylated  sites were 
heritable, namely those in the newly synthesized strands (i.e. 
DNA synthesized in the presence of butyrate) while pre- 
existing DNA strand hypermethylation was not heritable. 
This  discrimination may be  due to more  extensive methyla- 
tion at  non-CpG  sites  in  the  pre-existing DNA strands, i.e. at 
CpA, CpC, and  CpT sequences, while most of the  hypermeth- 
ylation induced on the newly synthesized DNA may be at  
CpG sites.  The  finding  that  hypermethylation f pre-existing 
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DNA strands occurred  with  a much higher  frequency and  at  
lower butyrate  concentrations also suggests that more CpX 
methylation occurred in  the  pre-existing DNA strands.  These 
findings were consistent when  dual-labeling experiments for 
pre-existing  and newly synthesized DNA strands  in  the  same 
cultures were employed. 
The  ability of sodium butyrate  to induce hypermethylation 
of DNA and the apparent differential heritability of this 
hypermethylated  state,  with respect to  pre-existing  and newly 
synthesized DNA strands, add further important effects of 
sodium butyrate to an  already  lengthy  list (2). It  is possible 
that  methylation levels are “fine tuned” by a demethylating 
enzyme and  that  butyrate  acts by inhibiting  this demethylase 
rather  than by stimulating  the  methyltransferases or by mak- 
















Prasad, K. N., and  Sinha, P. K. (1976) In   Vi tro 12, 125-132 
Kruh, J. (1982) Mol. Cell.  Biochem. 42, 65-82 
Wintersberger, E., Mudrak, I., and  Wintersberger, U. (1983) J. 
D’Anna, J. A., Tobey, R. A., and Gurley, L. R. (1980) Biochemistry 
Boffa, L. C., Gruss, R. J., and Allfrey, V. G. (1981) J .  Biol. Chem. 
Hagopian, H. K., Riggs, M. G., Swartz, L. A., and  Ingram, V. M. 
Daniell, E. (1980) Virology 107, 514-519 
Smerdon,  M.  J.,  Lan, S. Y., Calza, R. E., and Reeves, R. (1982) 
Smerdon,  M. J. (1983) Biochemistry 22, 3516-3525 
Riggs, M. G., Whittaker, R. G., Neumann, J. R.?  and  Ingram, V. 
Boffa, L. C., Vidali, G., Mann, R. S., and Allfrey, V. G. (1978) J. 
Candido, E. P. M., Reeves, R., and Davie, J. R. (1978) Cell 14, 
Sealy, L., and Chalkley, R. (1978) Cell 14, 115-121 
Nelson, D., Covault, J., and Chalkley, R. (1980) Nucleic Acids 
Cell. Biochem. 21, 239-247 
19,2656-2671 
256,9612-9621 
(1977) Cell 12,855-860 
J .  Biol.  Chem. 257, 13441-13447 
M. (1977) Nature 268, 462-464 
Biol.  Chem. 253,3364-3366 
105-113 
Res. 8, 1745-1763 
15. Dobson, M. E., and  Ingram, V. M. (1980) Nucleic Acids Res. 8, 
16. Csordas, A., Multhaup, I., and Grunicke, H. (1984) Biosci. Rep. 
17. Levy-Wilson, B. (1981) Proc.  Natl.  Acad.  Sci. U. S .  A. 78, 2189- 
18. Loidl, P., Loidl, A., Puschendorf, B., and Grobner, P. (1984) 
19. Reeves, R., and Cserjesi, P. (1979) J.  Biol. Chem. 254, 4283- 
20. Leibovitch, M., Leihovitch, S. Harel, J., and Kruh, J. (1982) 
21. Leder, A,, and Leder, P. (1975) Cell 5, 319-322 
22. Nozawa, S., Engvall, E., Kano, S., Kurihara, S., and Fishman, 
23. Jehangeer, S., Elliott, R. M., and  Henneberry, R. C. (1982) 
24. Ginder, G. D., Whitters, M. J.,  and  Pohlman, J. K. (1984) Proc. 
25. Christman, J. K., Price, P., Pedrinan, L., and Acs, G.  (1977) Eur. 
26. Van der Ploeg, L. H. T., Groffen, J., and Flavell, R. A. (1980) 
27. Weintraub, H., Larsen A., and Groudine, M. (1981) Cell 24, 333- 
28. Hoffman, R. M. (1984) Biochim.  Biophys.  Acta 738, 49-87 
29. Riggs, A. D., and  Jones, P. A. (1983) Adu.  Cancer  Res. 40, l -30  
30. Razin, A., and Riggs, A. D. (1980) Science 210, 604-610 
31. Zolan, M. E., Smith, A. C., Calvin, N. M., and Hanawalt, P. C. 
32. Parker, M. I., Judge, K., and Gevers, W. (1982) Nucleic Acids 
33. Wilson, V. L., and  Jones,  P. A. (1983) Cell 32, 239-246 
34. Jones,  P. A., and  Taylor, S. M. (1980) Cell 20, 85-92 
35. De Haan, J .  B.,  Gevers, W., and  Parker, M. I. (1986) Cancer  Res., 
36. Parker, M. I., and Gevers, W. (1984) Biochem. Biophys. Res. 
37. McKeon, C., Ohkubo, H., Pastan, I., and de Crombrugghe, B. 
38. Woodcock, D. M.,  Adams, J. K., and Cooper I. A. (1982) Biochim. 




Nucleic  Acids  Res. 12, 5405-5417 
4290 
Differentiation 22, 106-112 
W. H. (1983) Int. J .  Cancer 32, 267-272 
Biochem. Biophys. Res.  Commun. 108, 1434-1440 
Natl.  Acad.  Sci. U. S. A. 81, 3954-3958 
J.  Biochem. 81, 53-61 
Nucleic  Acids  Res. 8, 4563-4574 
344 
(1982) Nature 299, 462-464 
Res. 10, 5879-5891 
in press 
Commun. 124,236-243 
(1982) Cell 29, 203-210 
Biophys. Acta 696, 15-22 
Natl.  Acad.  Sci. U. S. A. 80, 4919-4921 
